Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced it will participate at the 37th Annual Roth ...

AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company developing innovative therapeutics in oncology, ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

particularly in challenging AML frontline populations. The trial showed high rates of composite complete response (CRc) and minimal residual disease (MRD) negativity without significant adverse events ...

Robinhood Markets (HOOD) stock dropped 13% in Monday morning trading as the retail trading app agreed to pay a $29.8M fine ...

A federal jury in San Francisco returned a guilty verdict for Rowland Marcus Andrade, the founder and CEO of NAC Foundation ...

TD Bank leadership called its response to anti-money laundering program lapses its "top priority" as federal regulators named ...

A healthy financial institution is well equipped to counteract anti-money laundering and combat the financing of terrorism, ...

The Financial Action Task Force (FATF) has published an updated version of its anti-money laundering (AML) and counter-terrorist financing ...